Opioid Antidote Higher Doses

2024. 2. 9. 05:54
글자크기 설정 파란원을 좌우로 움직이시면 글자크기가 변경 됩니다.

이 글자크기로 변경됩니다.

(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.

FILE - This image provided by Hikma Pharmaceuticals shows the company's nasal spray drug Kloxxado, containing 8 milligrams of naloxone. A study published Thursday, Feb. 8, 2024 finds that a new, higher-dose nasal spray for reversing opioid overdoses didn't save more lives than the standard dose. However, it was tied to more vomiting and other side effects. The paper was published by the Centers for Disease Control and Prevention, but the federal health agency was not involved in the research. (Hikma Pharmaceuticals via AP, File) AP PROVIDES ACCESS TO THIS THIRD PARTY PHOTO SOLELY TO ILLUSTRATE NEWS REPORTING OR COMMENTARY ON FACTS DEPICTED IN IMAGE; MUST BE USED WITHIN 14 DAYS FROM TRANSMISSION; NO ARCHIVING; NO LICENSING; MANDATORY CREDIT

▶제보는 카톡 okjebo

Copyright © 연합뉴스. 무단전재 -재배포, AI 학습 및 활용 금지

이 기사에 대해 어떻게 생각하시나요?